Brady Kelly
See Remarks
Brady Kelly has filed 2 SEC Form 4 filings (4 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Aug 18, 2026.
On the most recent filing, Brady Kelly is listed as See Remarks at Seres Therapeutics, Inc. Inside the rolling window, Brady Kelly reported no open-market purchases and 2 open-market sales totaling $735 in MCRB. The largest disclosed transaction in the window is a sale of 59 MCRB shares on May 18, 2026, worth $444.
Companies traded
Other insiders at MCRB
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$735
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Brady Kelly made?
Brady Kelly has filed 2 SEC Form 4 filings (4 transaction rows) across 1 company since 2026.
Which companies does Brady Kelly trade?
Brady Kelly has filed SEC Form 4 disclosures for 1 company, including MCRB.
When was Brady Kelly's most recent SEC Form 4 filing?
Brady Kelly's most recent SEC Form 4 filing on Tracefour is dated Aug 18, 2026.
What is Brady Kelly's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Brady Kelly is listed as See Remarks.
What is Brady Kelly's total buy and sell value in the current window?
Inside the rolling retention window, Brady Kelly bought $0 and sold $735 based on SEC Form 4 filings.
What was Brady Kelly's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 59 MCRB shares on 2026-05-18, worth $444, per SEC Form 4 filings.